TBG Diagnostics Limited announced consolidated earnings results for the year ended December 31, 2018. for the year, the company reported revenue from continuing operations of AUD 3,152,830 compared to AUD 3,451,379 a year ago. Net loss for the year was AUD 4,393,330 compared to AUD 6,547,692 a year ago. Basic loss per share was 2.0 cents compared to 3.0 cents a year ago. Basic and diluted loss per share ­ continuing operations attributable to equity holders of the Company was 1.2 cents compared to 0.8 cents a year ago.